文献速递免疫规划卫生政策与健康促进

津巴布韦地区和卫生机构层面人乳头瘤病毒疫苗接种成本:针对多队列的学校接种项目

Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts.
PubMed 文献 · Vaccine · 2022-02-15

该研究对津巴布韦2018和2019年国家人乳头瘤病毒(HPV)疫苗接种项目进行回顾性增量成本分析,从提供方视角估算地区和卫生机构层面的财务与经济成本。结果显示,服务提供每剂加权成本为财务0.16美元、经济0.59美元;村卫生工作者动员校外女孩额外增加每剂财务2.99美元、经济7.79美元。

要点

  • 服务提供每剂加权成本:财务0.16美元,经济0.59美元。
  • 培训占总加权财务成本37%,服务提供占30%。
  • 村卫生工作者覆盖校外女孩每剂额外财务2.99美元、经济7.79美元。

核心结论

  • 服务提供每剂成本低于津巴布韦试点项目成本分析及其他地区研究报告的水平,反映大规模接种队列分摊固定成本的运动式接种方式。
  • 首次在中低收入国家记录覆盖校外女孩接种HPV疫苗的额外成本,可为其他国家潜在成本提供信息。

研究设计与样本

  • 回顾性、增量、基于投入品的成本分析,从提供方视角开展。
  • 数据收集于2018和2019年,采用两阶段整群抽样,覆盖地区和卫生机构层面,按项目活动、资源投入、付款方和行政层级四个成本维度。
  • 成本以2020年美元表示,报告总成本和每剂成本。

主要发现

  • 地区和卫生机构合并层面的总加权成本:财务828,731美元,经济2,060,943美元。
  • 服务提供每剂加权总成本:财务0.16美元,经济0.59美元。
  • 总加权财务成本中占比最大的项目活动为培训(37%)和服务提供(30%);总加权经济成本中占比最大的为服务提供(45%)和培训(19%)。
  • 村卫生工作者覆盖校外女孩的努力导致每剂额外财务成本2.99美元、经济成本7.79美元。
  • 2018和2019年接种活动期间,津巴布韦报告接种HPV疫苗1,569,905剂。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After a pilot project in 2014-15 Zimbabwe introduced the human papillomavirus (HPV) vaccine nationally in 2018 for girls aged 10-14 years through a primarily school-based vaccination campaign with two doses administered at 12-month intervals. In 2019, a first dose was delivered to a new cohort of girls in grade 5 of girls age 10 years if out-of-school (OOS), along with a second dose to the 2018 multiple cohorts. Additional effort was made to identify and mobilize OOS girls by Village Health Workers (VHWs) in the community. Zimbabwe reported 1,569,905 doses of HPV vaccine administered during the 2018 and 2019 campaigns. This analysis evaluated the cost of Zimbabwe's national HPV vaccine introduction. METHODS: A retrospective, incremental, ingredients-based cost analysis from the provider perspective was conducted in 2018 and 2019. Financial and economic cost data were collected at district and health facility levels using a two-stage cluster sampling approach and four cost dimensions: program activity, resource input, payer, and administrative level. Costs are presented in 2020 US$ in total and per dose. RESULTS: The total weighted costs for combined district and health facility administrative levels were US$ 828,731 (financial) and US$ 2,060,943 (economic). For service delivery, the total weighted cost per dose was US$ 0.16 (financial) and US$ 0.59 (economic). The program activities with the largest share of total weighted financial cost were training (37% of total) and service delivery (30%), while the largest shares of total weighted economic costs were service delivery (45%) and training (19%). Efforts by VHWs to reach OOS girls resulted in an additional US$ 2.99 in financial cost per dose and US$ 7.79 in economic cost per dose. CONCLUSION: The service delivery cost per dose was lower than that documented in the pilot program cost analysis in Zimbabwe and studies elsewhere, reflecting a campaign delivery approach that spread fixed costs over a large vaccination cohort. The additional cost of reaching OOS girls with the HPV vaccine was documented for the first time in low- and middle-income countries, which may provide information on potential costs for other countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hidle A, Brennan T, Garon J, et al. Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts. Vaccine. 2022. PMID: 35181152. doi:10.1016/j.vaccine.2022.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。